Zhao Yaqi, Xu Wei, Gao Wenfeng, Li Xinya, Liu Baocheng, Yan Suyan, Ma Zhenzhen, Yang Qingrui
Department of Rheumatology and Immunology, Shandong Provincial Hospital, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, China.
Department of Rheumatology and Immunology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China.
Clin Rheumatol. 2024 May;43(5):1635-1646. doi: 10.1007/s10067-024-06936-1. Epub 2024 Mar 15.
Systemic sclerosis (SSc) is a heterogeneous connective tissue disease that is commonly subdivided into limited cutaneous SSc (lcSSc) and diffuse cutaneous SSc (dcSSc) based on the extent of skin involvement. This subclassification may not reflect the full range of clinical phenotypic variation. This study aimed to investigate clinical features and aggregation of patients with SSc in Chinese based on SSc manifestations and organ involvements, in order to achieve precise treatment of SSc early prevention of complications.
In total 287 SSc patients were included in this study. A cluster analysis was applied according to 13 clinical and serologic variables to determine subgroups of patients. Survival rates between obtained clusters and risk factors affecting prognosis were also compared.
In this study, six clusters were observed: cluster 1 (n = 66) represented the skin type, with all patients showing skin thickening. In cluster 2 (n = 56), most patients had vascular and articular involvement. Cluster 3 (n = 14) individuals mostly had cardiac and pulmonary involvement. In cluster 4 (n = 52), the gastrointestinal type, 50 patients presented with stomach symptoms and 28 patients presented with esophageal symptoms. In cluster 5 (n = 50), patients barely had any major organ involvement. Cluster 6 (n = 49) included 46% of all patients presenting with renal crisis.
The results of our cluster analysis study implied that limiting SSc patient subgroups to those based only on skin involvement might not capture the full heterogeneity of the disease. Organ damage and antibody profiles should be considered when identifying homogeneous patient groups with a specific prognosis. Key Points • Provides a new method of categorizing SSc patients. • Can better explain disease progression and guide subsequent treatment.
系统性硬化症(SSc)是一种异质性结缔组织病,通常根据皮肤受累程度分为局限性皮肤型SSc(lcSSc)和弥漫性皮肤型SSc(dcSSc)。这种亚分类可能无法反映临床表型变异的全部范围。本研究旨在根据SSc的表现和器官受累情况,调查中国SSc患者的临床特征和聚集情况,以便实现SSc的精准治疗和并发症的早期预防。
本研究共纳入287例SSc患者。根据13项临床和血清学变量进行聚类分析以确定患者亚组。还比较了所得聚类之间的生存率以及影响预后的危险因素。
在本研究中,观察到六个聚类:聚类1(n = 66)代表皮肤型,所有患者均表现为皮肤增厚。在聚类2(n = 56)中,大多数患者有血管和关节受累。聚类3(n = 14)的个体大多有心脏和肺部受累。在聚类4(n = 52)即胃肠型中,50例患者有胃部症状,28例患者有食管症状。在聚类5(n = 50)中,患者几乎没有任何主要器官受累。聚类6(n = 49)包括所有出现肾危象患者的46%。
我们聚类分析研究的结果表明,将SSc患者亚组仅局限于基于皮肤受累情况可能无法涵盖该疾病的全部异质性。在确定具有特定预后的同质患者群体时,应考虑器官损害和抗体谱。要点 • 提供了一种对SSc患者进行分类的新方法。 • 能更好地解释疾病进展并指导后续治疗。